Join Industry Leading Professionals at the marcus evans 2nd Global Pharmacovigilance & Adverse Event Reporting Conference
Reinerio A. Deza answered a series of questions written by marcus evans before the forthcoming 2nd Global Pharmacovigilance & Adverse Event Reporting Conference, May 22-24, 2012 in Boston, MA. All responses represent the view of Mr. Deza and not necessarily those of Cubist Pharmaceuticals, Inc.

Many pharmaceutical companies are facing budget cuts and also increased expectations to have a robust drug safety function. How does outsourcing play into this situation?

RD: Outsourcing can be leveraged to provide support for the common or ordinary business activities, allowing the company’s safety staff experts to focus and address critical or complex safety reviews/assessments/reports. Similarly if the company does not have the subject matter experts, outsourcing can fill the gap.

What can companies do to maximize their...